Rivaroxaban Effective In Medically Ill Patients But At High Bleeding Cost

The recent arrival of novel oral anticoagulants has provided important new options for venous thromboembolism (VTE) treatment and prevention. New indications for these drugs have been granted for patients with atrial fibrillation and following orthopedic surgery. But an additional indication, for acutely ill medical patients at risk for VTE, does not appear likely in the near future, as a new trial published in the New England Journal of Medicine shows that one of these novel drugs, though effective at preventing VTE, also resulted in a significant increase in bleeding risk. In the Multicenter, Randomized, Parallel Group More…
Source: CardioBrief - Category: Cardiology Authors: Tags: Heart Rhythms Prevention, Epidemiology & Outcomes Anticoagulant atrial fibrillation Enoxaparin sodium rivaroxaban Venous thrombosis VTE Source Type: blogs